'New paradigm' moment as mRNA cancer vaccine slashes risk of tumor relapse or death
Pharma giants Merck and Moderna which developed the shot today heralded the results as 'spectacular' and a 'tremendous step forward'. It targets high-risk melanoma.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Health | Melanoma | Merck | Pharmaceuticals | Skin Cancer | Vaccines